Market Insight on FDA-approvals: Rise of First-in-class and Regenerative Innovations

2022-03-17| In-DepthTrials & Approvals

Market Insight on FDA-approvals: Rise of First-in-class and Regenerative Innovations

by GeneOnline

Share To

Achieving market entry for new drugs has never been more challenging, especially for non-COVID medications during a time shrouded in COVID-19. Notably, the US FDA has pushed to accelerate the launches of non-COVID medications and has been reviewing more next-generation (Next-Gen) drugs in the last 14 months. Next-Gen drugs, here chiefly describing the first-in-class and regeneration ones which encompass strong clinical benefits and market competitions, are evolving fast year on year.

GO Prime with only $1.49 now

SUBSCRIBE NOW

LATEST

AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan

2022-09-28

GO PRIME

Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial

2022-09-28

Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech

2022-09-27

Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics

2022-09-27

Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study

2022-09-27

Daiichi Sankyo Wins Approval For Cancer Treatment in Japan

2022-09-26

Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment

2022-09-26

EVENT

2022-10-12

BioJapan / Regenerative Medicine Japan / healthTECH JAPAN 2022

Japan

2022-10-26

Brussels, Belgium – EFIB 2022

Brussels, Belgium

2022-11-07

2nd World Congress on Primary Healthcare and Medicare Summit

Paris, France

2022-11-07

BioFuture | Beyond Disruption: The New Age of Healthcare and Technology

New York city

2022-11-14

MEDICA2022

Germany

2022-12-10

64TH ASH ANNUAL MEETING & EXPOSITION

New Orleans, Louisiana

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

GENE ONLINE|News &
Opinion
Blog